Oral Antituberculosis Drugs Market, Global Outlook and Forecast 2024-2030
This report aims to provide a comprehensive presentation of the global market for Oral Antituberculosis Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Antituberculosis Drugs. This report contains market size and forecasts of Oral Antituberculosis Drugs in global, including the following market information:
Global Oral Antituberculosis Drugs Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
The global Oral Antituberculosis Drugs market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Isoniazid Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Oral Antituberculosis Drugs include Lupin, Macleods Pharmaceuticals, Otsuka Pharmaceutical, Johnson & Johnson, Pfizer, Novartis, Abbott, AstraZeneca and Bayer, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
We surveyed the Oral Antituberculosis Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oral Antituberculosis Drugs Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Oral Antituberculosis Drugs Market Segment Percentages, by Type, 2023 (%)
Isoniazid
Rifampin
Ethambutol
Pyrazinamide
Otherr
Global Oral Antituberculosis Drugs Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Oral Antituberculosis Drugs Market Segment Percentages, by Application, 2023 (%)
Hospitals and Clinics
Government Agencies
Non-Profit Organizations
Others
Global Oral Antituberculosis Drugs Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Oral Antituberculosis Drugs Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oral Antituberculosis Drugs revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Oral Antituberculosis Drugs revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Lupin
Macleods Pharmaceuticals
Otsuka Pharmaceutical
Johnson & Johnson
Pfizer
Novartis
Abbott
AstraZeneca
Bayer
Eli Lilly
GlaxoSmithKline
Merck
Sanofi
Chongqing Huapont Pharm
Shuangding Pharm
Hongqi pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Oral Antituberculosis Drugs, market overview.
Chapter 2: Global Oral Antituberculosis Drugs market size in revenue.
Chapter 3: Detailed analysis of Oral Antituberculosis Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oral Antituberculosis Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
